Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 5 studies | 34% ± 14% | |
GABAergic neuron | 4 studies | 24% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 31% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 92% | 5814.99 | 2422 / 2642 | 83% | 16.42 | 582 / 705 |
stomach | 2% | 6.37 | 6 / 359 | 50% | 3.47 | 142 / 286 |
intestine | 2% | 6.38 | 17 / 966 | 48% | 3.26 | 254 / 527 |
pancreas | 4% | 19.59 | 13 / 328 | 45% | 3.14 | 80 / 178 |
ovary | 1% | 3.95 | 1 / 180 | 39% | 2.87 | 168 / 430 |
esophagus | 0% | 0.19 | 1 / 1445 | 30% | 2.37 | 55 / 183 |
uterus | 1% | 5.49 | 2 / 170 | 15% | 1.16 | 67 / 459 |
lung | 0% | 0 | 0 / 578 | 14% | 0.83 | 162 / 1155 |
bladder | 0% | 0 | 0 / 21 | 13% | 0.67 | 65 / 504 |
tonsil | 0% | 0 | 0 / 0 | 11% | 0.63 | 5 / 45 |
thymus | 0% | 3.61 | 2 / 653 | 11% | 1.27 | 64 / 605 |
adrenal gland | 0% | 1.74 | 1 / 258 | 5% | 0.57 | 12 / 230 |
kidney | 0% | 0 | 0 / 89 | 5% | 0.29 | 49 / 901 |
breast | 0% | 0 | 0 / 459 | 2% | 0.07 | 25 / 1118 |
liver | 0% | 0 | 0 / 226 | 1% | 0.03 | 6 / 406 |
eye | 0% | 0 | 0 / 0 | 1% | 0.04 | 1 / 80 |
skin | 0% | 0.53 | 1 / 1809 | 1% | 0.01 | 3 / 472 |
prostate | 0% | 0 | 0 / 245 | 1% | 0.01 | 3 / 502 |
adipose | 0% | 0.88 | 3 / 1204 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.41 | 1 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 1.68 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042177 | Biological process | negative regulation of protein catabolic process |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0043278 | Biological process | response to morphine |
GO_0007611 | Biological process | learning or memory |
GO_0007635 | Biological process | chemosensory behavior |
GO_0032425 | Biological process | positive regulation of mismatch repair |
GO_1990911 | Biological process | response to psychosocial stress |
GO_0060291 | Biological process | long-term synaptic potentiation |
GO_1901799 | Biological process | negative regulation of proteasomal protein catabolic process |
GO_0042752 | Biological process | regulation of circadian rhythm |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0031397 | Biological process | negative regulation of protein ubiquitination |
GO_0048265 | Biological process | response to pain |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0099171 | Biological process | presynaptic modulation of chemical synaptic transmission |
GO_0050764 | Biological process | regulation of phagocytosis |
GO_0016310 | Biological process | phosphorylation |
GO_0006468 | Biological process | protein phosphorylation |
GO_0009636 | Biological process | response to toxic substance |
GO_0032095 | Biological process | regulation of response to food |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0060384 | Biological process | innervation |
GO_0048511 | Biological process | rhythmic process |
GO_2000300 | Biological process | regulation of synaptic vesicle exocytosis |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0097060 | Cellular component | synaptic membrane |
GO_0030425 | Cellular component | dendrite |
GO_0005911 | Cellular component | cell-cell junction |
GO_0044305 | Cellular component | calyx of Held |
GO_0005829 | Cellular component | cytosol |
GO_0014069 | Cellular component | postsynaptic density |
GO_0099524 | Cellular component | postsynaptic cytosol |
GO_0099523 | Cellular component | presynaptic cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0004712 | Molecular function | protein serine/threonine/tyrosine kinase activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0004672 | Molecular function | protein kinase activity |
GO_0004698 | Molecular function | calcium,diacylglycerol-dependent serine/threonine kinase activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0004697 | Molecular function | diacylglycerol-dependent serine/threonine kinase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PRKCG |
Protein name | Protein kinase C gamma Protein kinase C gamma type (PKC-gamma) (EC 2.7.11.13) Protein kinase C (EC 2.7.11.13) |
Synonyms | PKCG |
Description | FUNCTION: Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays diverse roles in neuronal cells and eye tissues, such as regulation of the neuronal receptors GRIA4/GLUR4 and GRIN1/NMDAR1, modulation of receptors and neuronal functions related to sensitivity to opiates, pain and alcohol, mediation of synaptic function and cell survival after ischemia, and inhibition of gap junction activity after oxidative stress. Binds and phosphorylates GRIA4/GLUR4 glutamate receptor and regulates its function by increasing plasma membrane-associated GRIA4 expression. In primary cerebellar neurons treated with the agonist 3,5-dihyidroxyphenylglycine, functions downstream of the metabotropic glutamate receptor GRM5/MGLUR5 and phosphorylates GRIN1/NMDAR1 receptor which plays a key role in synaptic plasticity, synaptogenesis, excitotoxicity, memory acquisition and learning. May be involved in the regulation of hippocampal long-term potentiation (LTP), but may be not necessary for the process of synaptic plasticity. May be involved in desensitization of mu-type opioid receptor-mediated G-protein activation in the spinal cord, and may be critical for the development and/or maintenance of morphine-induced reinforcing effects in the limbic forebrain. May modulate the functionality of mu-type-opioid receptors by participating in a signaling pathway which leads to the phosphorylation and degradation of opioid receptors. May also contributes to chronic morphine-induced changes in nociceptive processing. Plays a role in neuropathic pain mechanisms and contributes to the maintenance of the allodynia pain produced by peripheral inflammation. Plays an important role in initial sensitivity and tolerance to ethanol, by mediating the behavioral effects of ethanol as well as the effects of this drug on the GABA(A) receptors. During and after cerebral ischemia modulate neurotransmission and cell survival in synaptic membranes, and is involved in insulin-induced inhibition of necrosis, an important mechanism for minimizing ischemic injury. Required for the elimination of multiple climbing fibers during innervation of Purkinje cells in developing cerebellum. Is activated in lens epithelial cells upon hydrogen peroxide treatment, and phosphorylates connexin-43 (GJA1/CX43), resulting in disassembly of GJA1 gap junction plaques and inhibition of gap junction activity which could provide a protective effect against oxidative stress (By similarity). Phosphorylates p53/TP53 and promotes p53/TP53-dependent apoptosis in response to DNA damage. Involved in the phase resetting of the cerebral cortex circadian clock during temporally restricted feeding. Stabilizes the core clock component BMAL1 by interfering with its ubiquitination, thus suppressing its degradation, resulting in phase resetting of the cerebral cortex clock (By similarity). . |
Accessions | M0R0Z4 ENST00000419486.1 A0A804HHY0 ENST00000474397.5 ENST00000479081.5 P05129 A0A804HIU5 ENST00000683513.1 ENST00000263431.4 [P05129-1] M0R0I9 H7BZ60 ENST00000682028.1 |